EUVIMEDEUVIMED entdecken
Crossref

Protocatechuic Acid Improves Alzheimer's Disease by Regulating the Cholinergic Synaptic Signaling Pathway

Siwen Li, Songtao Li, Rasmané Semde, Hongbo Teng, Mengqi Shi, Liang Huang, Xinru Lou, Beining Jia, Hongyan Zhu iD, Yan Zhao

Chemistry & Biodiversity · 2025-05 · 22 (5)

DOI: 10.1002/cbdv.202402771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 27.01.2025. Verfasst von Siwen Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Hydroxybenzoates, Neuroprotective Agents, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Jilin Provincial Scientific and Technology Plan Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by memory decline and cognitive impairments. The clinical treatments for AD have numerous adverse effects; hence, the exploration of natural products for AD therapy is of significant importance. Protocatechuic acid (PA), a natural phenolic acid, has been shown to possess various pharmacological activities, including anti‐inflammatory, antioxidant, and antitumor effects. However, the mechanisms underlying its therapeutic potential for AD remain elusive. This study utilized a β‐amyloid (Aβ) injection into the hippocampus of mice as an AD model and L‐glu‐induced HT‐22 cell neurotoxicity and lipopolysaccharides (LPS)‐induced cellular neuroinflammation models to assess reactive oxygen species (ROS), JC‐1, and relevant biochemical markers. This study examined behavioral, pathological, and inflammatory factors and investigated the molecular mechanisms through transcriptomics, western blot, and molecular docking studies. This study's findings reveal that high‐dose PA (50 mg/kg) improves symptoms in AD mice through the cholinergic synaptic signaling pathway. This study indicates that PA is a potential candidate for AD treatment targeting the cholinergic synaptic signaling pathway, providing a lead compound for AD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHydroxybenzoatesNeuroprotective AgentsSignal TransductionAnimalsHumansMaleMiceAmyloid beta-PeptidesDisease Models, AnimalHippocampusLipopolysaccharidesMolecular Docking SimulationReactive Oxygen SpeciesBenzyl Alcohols

Stichwörter der Autor:innen

Alzheimer's diseasecholinergic synapseneuroinflammationneurotoxicity oxidative stress

Substanzen

Amyloid beta-PeptidesHydroxybenzoatesLipopolysaccharidesNeuroprotective Agentsprotocatechuic acidReactive Oxygen SpeciesBenzyl Alcohols

Autor:innen und Institutionen

  • College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
  • International Joint Laboratory for Development of Animal and Plant Resources for Food and Medicine, Changchun, China.
  • Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • Synthèse des médicaments, CEA-CFOREM, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.

ORCID-Profile: Hongyan Zhu

Förderung

  • Jilin Provincial Scientific and Technology Plan Projects

Zitieren

APA

Li, S., Li, S., Semde, R., Teng, H., Shi, M., Huang, L., Lou, X., Jia, B., Zhu, H., & Zhao, Y. (2025). Protocatechuic Acid Improves Alzheimer's Disease by Regulating the Cholinergic Synaptic Signaling Pathway. Chemistry & Biodiversity, 22(5). https://doi.org/10.1002/cbdv.202402771

Vancouver

Li S, Li S, Semde R, Teng H, Shi M, Huang L, et al. Protocatechuic Acid Improves Alzheimer's Disease by Regulating the Cholinergic Synaptic Signaling Pathway. Chemistry & Biodiversity. 2025;22(5). doi:10.1002/cbdv.202402771

BibTeX
@article{Li2025,
  author = {Li, Siwen and Li, Songtao and Semde, Rasmané and Teng, Hongbo and Shi, Mengqi and Huang, Liang and Lou, Xinru and Jia, Beining and Zhu, Hongyan and Zhao, Yan},
  title = {Protocatechuic Acid Improves Alzheimer's Disease by Regulating the Cholinergic Synaptic Signaling Pathway},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  volume = {22},
  number = {5},
  doi = {10.1002/cbdv.202402771}
}
Kostenlos starten →